Company intelligence / Profile preview

Joyn Bio

Boston, Massachusetts, United States

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Joyn Bio is developing engineered microbial products to enable cereal crops such as corn, wheat, and rice to fix atmospheric nitrogen and to provide biological crop protection and fertility solutions; products are in R&D and not yet commercialized.[3][4]

Modalities: Microbial therapyLive biotherapeutic product therapyBiologic
Industry: Agriculture & AgTech

Partnerships

Bayer (including Leaps by Bayer and Bayer Crop Science)Ginkgo BioworksViking Global Investors (Series A investor via Bayer/Ginkgo announcement)

Beyond the preview

Go deeper on Joyn Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joyn Bio.

Explore the full profile